Clinical Trial Update: Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a vaccine therapy in Philadelphia chromosome-positive chronic myeloid leukemia (CML) completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Leukemia

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-08-28